RVTY Stock Analysis: Buy, Sell, or Hold?
RVTY - Revvity, Inc.
$99.90
0.86 (0.87%)
▲
5d:
-0.65%
30d:
+4.74%
90d:
+14.62%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 27, 2026
Get Alerted When RVTY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RVTY shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: RVTY shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$142.79
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$88.66
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RVTY is currently trading at $99.90, which is considered fair relative to its 30-day fair value range of $96.48 to $101.99. The stock's valuation (Forward PE: 17.1) is in line with its historical norms (17.0). At these levels, the market is pricing in 0.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, RVTY is in a downtrend. Immediate support is located at $95.72, while resistance sits at $106.09.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $113.64 (+13.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RVTY is in a downtrend. Immediate support is located at $95.72, while resistance sits at $106.09.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $113.64 (+13.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$96.48 -
$101.99
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($113.64)
- NEUTRAL: Market pricing in 0.2% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$96.48 -
$101.99
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$6.13
(6.1%)
Support & Resistance Levels
Support Level
$95.72
Resistance Level
$106.10
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.13
Wall Street Target
$113.64
(+13.8%)
Revenue Growth (YoY)
7.0%
Earnings Growth (YoY)
3.5%
Profit Margin
8.3%
Valuation Premium vs History
+0.2% premium
PE vs Historical
17.1 vs 17.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.2%
(market-implied from PE analysis)
1-Year Target
$100.10
(+0%)
2-Year Target
$100.30
(+0%)
3-Year Target
$100.50
(+1%)
3-Yr Target (if PE normalizes)
(PE: 17→17)
PE COMPRESSION
$99.73
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.2%)
$174.56
(+75%)
Base:
(SPY PE: 17.1, Growth: 11.2%)
$137.30
(+37%)
Bear:
(PE: 14.6, Growth: 11.2%)
$116.70
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (48x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 47.62 | Current EPS (TTM): $2.08
Bull Case
$217.89
(+118%)
Analyst growth 100.0%, PE expands to 52.4
Base Case
$198.08
(+98%)
Market implied 100.0%, PE stable at 47.6
Bear Case
$67.35
(-33%)
Severe decline -20.0%, PE contracts to 40.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 7:54 PM ET
Data refreshes hourly during market hours. Next update: 8:54 PM
Data refreshes hourly during market hours. Next update: 8:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RVTY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Anita Gonzales
SELL
80 shares
2026-04-20
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 59 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 63 BUY |
Advanced RVTY Option Strategies
Professional options setups generated by AI based on today's RVTY price and gamma walls.
